EYE vs PNV

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

EYE

NOVA EYE FPO [EYE]

57MEDIUM

PNV

POLYNOVO FPO [PNV]

53MEDIUM

Score Breakdown

EYE PNV
Technical
57
47
Catalyst
53
61
Sentiment
50
50
Fundamental
76
87
Momentum
39
54
Risk Gate
45
35

Key Metrics

EYE Metric PNV
$32.8MMarket Cap$708.1M
269KAvg Volume (20d)1.8M
N/AShort Interest+8.6%
$0.20552-Week High$1.665
$0.10052-Week Low$0.865
+0.0%Daily Change-0.3%
$0.115Reference Price$1.017
-42.4%ROE+12.5%
-21.3%Profit Margin+7.1%

Active Signals

EYE Signals

●MACD momentum is picking up steam
●Stochastic is stretched into overbought — could need a breather
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Low cash runway (2 quarters) - dilution risk
●Low P/S ratio (1.0x)
●Strong revenue growth (+29%)
●EPS estimates revised upward (+10pts)

PNV Signals

●Knocking on the door of resistance — if it punches through, things could get interesting
●Volume-price trend suggests distribution — sellers may be sneaking out while price holds
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Moderate P/S ratio (5.1x)
●Moderate revenue growth (+18%)
●Piotroski F-Score strong (8/9, low-confidence approx)
●EPS estimates revised upward (+10pts)

Ask Scout AI to compare EYE and PNV in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

EYE vs PTX →EYE vs RHT →EYE vs SOM →EYE vs SPL →EZZ vs HMD →
EYE Full Analysis → PNV Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).